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Summary 
Lsk is a protein tyrosine kinase with homology to the COOH-terminal Src kinase (Csk). Unlike 
Csk that is ubiquitously expressed, Lsk has limited tissue distribution. Here we have examined 
the expression and regulation of Lsk and Csk in peripheral human monocytes. We have found 
that Lsk mRNA and protein were not expressed in resting monocytes but were induced  by treatment 
with interleukin 4 (IL-4)  or IL-13 but not by interferon 3' (IFN-3')  or IL-2.  In fact,  IFN-3', 
but not IL-2, efficiently blocked Lsk induction by IL-4 or IL-13. In contrast, Csk was constitutively 
present in human monocytes and was upregulated by IFN-3' but not by IL-4 or IL-13. These 
results suggest that despite their structural similarities, Lsk and Csk may play distinct regulatory 
roles in monocyte functions elicited by cytokines, with Lsk functioning specifically within the 
context of a Th2-type immune response. 
T 
he phosphorylation of tyrosine residues by protein tyro- 
sine kinases (PTKs) plays a central role in normal cel- 
lular growth and differentiation as well as oncogenesis. The 
10 PTKs of the Src family (c-Src, c-Yes, Fyn, Yrk, c-Fgr, Lyn, 
Lck,  Hck,  Blk,  and Rak)  have been extensively  studied. 
Whereas c-Src and c-Yes are widely expressed in tissues, other 
members of the Src family have a lineage-specific pattern of 
expression.  For example, Lck is mainly expressed in T lym- 
phocytes and natural killer cells and Blk is restricted to B 
cells. The principle Src-family PTKs in monocytes/macro- 
phages are Hck, Fgr, Lyn, and Yrk; however, little is known 
about their function and regulation in these cells (1,  2). 
Nonetheless there is increasing evidence that tyrosine phos- 
phorylation is important in monocytic functions. In mono- 
cytes, PTK activation has been shown to be required for the 
induction of cytokines by LPS (3) and Fc receptor-mediated 
phagocytosis (4, 5). In addition, both physical and functional 
association  between Fc receptors  and Src family PTK have 
been found (4, 5) and Fgr, Hck, and Lyn are regulated during 
macrophage activation by LPS and IFN-3" (6,  7). 
The functions of Src-family PTKs are negatively regulated 
by phosphorylation of a highly conserved COOH-terminal 
tyrosine residue (Tyr 527 of Src) (8). COOH-terminal Src 
kinase (Csk), a ubiquitous nonreceptor tyrosine kinase, has 
been shown to be capable of specifically phosphorylating the 
negative regulatory sites of c-Src, Lck, Blk, and Fyn (9-11). 
Csk kinase differs from Src family members as it lacks myristoy- 
lation (Gly 2 of Src), and autophosphorylation sites, as well 
as the putative negative regulatory COOH-terminal tyro- 
sine residue (11-13). These characteristics have suggested that 
Csk may be a member of a new class of nonreceptor PTKs 
involved in the downregulation of Src-famfly PTK kinase ac- 
tivity (12). We have recently cloned a highly related Csk-like 
gene, Lsk (leukocyte COOH-terminal Src-kinase) from acti- 
vated peripheral blood T cells (14) and we have demonstrated 
the presence of abundant Lsk mRNA in natural killer cells 
and brain, with little or no expression in a variety of other 
tissues. In addition, several other groups have cloned genes 
highly homologous to Lsk (15-18). 
This weft-defined role of Src-family PTKs in monocyte/mac- 
rophage function in conjunction with the identification of 
a Csk-like kinase with preferential expression in the immune 
system led us to examine the regulation of the Csk family 
in normal human monocytes. We report here that although 
Lsk mRNA and protein were not constitutively expressed 
in untreated monocytes, the kinase was induced after treat- 
ment of monocytes with IL-4 or IL-13 and that induction 
was blocked by IFN-3'. In sharp contrast, Csk mRNA and 
protein were constitutively present in human monocytes and 
were upregulated by IFN-3" but not IL-4 or IL-13. This sug- 
gests that the expression of Lsk is highly regulated in mono- 
cytes by cytokines invoked during a Th2-type immune re- 
sponse, perhaps implying a specific role for Lsk in monocytes 
during these responses. 
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Cell  Culture.  Monocytes  were purified from PBMC by cen- 
trifugal elutriation as described elsewhere (19). The purity of the 
monocyte preparations used in these study was 93%  + 3% as as- 
sessed by morphology on Giemsa-stained  cytocentrifuge prepara- 
tions and flow cytometry  using the monocyte-specific  mAb, LeuM3. 
Cells were cultured in RPMI 1640 (Advanced  Biotechnologies,  Inc., 
Columbia, MD), containing 100.  U/ml penicillin, 100/~g/ml strep- 
tomycin, 2 mmol/liter r-glutamine, 20 mmol/liter Hepes (Gibco 
BRL, Gaithersburg, MD); and 10% heat-inactivated fetal bovine 
serum (HyClone Laboratories, Inc., Logan, UT). 
Cytokines.  Human recombinant IFN-y (lot NN9027AX,  sp 
act 2.02 x  107 U/mg) was kindly provided by Dr. H. M. Shephard 
(Genentech, San Francisco,  CA). Human recombinant II~4  was ob- 
tained from Pepro Tech (Rocky Hill, NJ). Human recombinant 
II.,13 was kindly provided by Sanofi Elf Bio Recherche (Lab~ge, 
France; 0.2-0.5 rig/m1 of Chinese hamster ovary-derived  I1:13 sup- 
ports 50% maximum proliferation of the TF-1 cell line). Recom- 
binant purified I1:2 from Escherichia coli (lot LP-381, sp act of 18 x 
106 IU/mg, and LPS content of <0.0006 ng/ml) was kindly pro- 
vided by Cetus Corp. (Emeryville, CA). 
Northern Blot Analysis.  For RNA extraction, 5  x  107 mono- 
cytes were plated in 25 ml medium alone or supplemented with 
the indicated cytokines. Total mRNA isolation and Northern blot 
analysis were performed as described (19). mRNA expression was 
quantitated by digital scanning of autoradiographs and the values 
reported are the average _+  standard deviation where the control 
expression is represented as 1.0. 
Western Blot Analysis.  50  x  106 monocytes were cultured in 
medium alone or in the presence  of the indicated  cytokines  for 48 h. 
Cells were washed in PBS and lysed  by boiling in Laemmli sample 
buffer. Insoluble  material  was removed  by centrifugation  for 30 min 
at 10,000 g, protein content of the clarified  lysate was determined 
using a protein assay  kit (Bio-Rad Laboratories, Richmond, CA) 
and equal amounts of protein from each sample were subjected to 
SDS-PAGE, and immunoblotted with a polyclonal rabbit serum 
generated to the predicted COOH-terminal of the Lsk protein (14) 
or with polyclonal  anti-Csk antiserum (kind gift of Dr. M. Okada, 
Osaka, Japan) as described (14). 
Results 
Differential  Regulation  of Lsk  and  Csk  in  Human  Mono- 
cytes.  IFN-3, is a potent activator of several human mono- 
cyte functions. Many of the monocyte/macrophage activities 
induced by IFN-3' as well as other monocyte activators  can 
be downregulated by IL-4. In addition, IL-4 induces the ex- 
pression of certain monocyte/macrophage surface antigens 
including MHC class II molecules and CD23 (20). To estab- 
lish if  IFN-y or IL-4 could regulate Lsk expression, total RNA 
was obtained from monocytes cultured for 18 h with medium 
alone or supplemented with IL-4 (100 U/ml), IFN-3' (500 
U/ml), or IL-4 (100 U/ml) plus IFN-3, (500 U/ml). As shown 
in Fig.  1 A, Lsk mRNA was not constitutively expressed 
in untreated monocytes. Interestingly, the monocyte activator 
IFN-3' failed to induce significant Lsk mRNA increase com- 
pared to unstimulated monocytes (1.17 +_ 0.26 times the level 
of the medium control, n  =  5) (Fig. 1 A, lane 3) as did LPS, 
IL-1, and TNF (data not shown). In contrast, treatment of 
monocytes with IL-4 induced a pronounced increase of Lsk 
mRNA (9.42  _+  2.7 times the level of the medium control, 
Figure 1.  Effect  of  IL-4  and IFN-3"  on Lsk and Csk expression.  Northern 
blot analysis  of the expression of Lsk mlLNA  (A) or Csk mRNA (B) in 
human monocytes  cultured for 18 h with medium alone (lane I); Ib4, 
100 U/ml (lane  2); IFN-% 500 U/ml (lane  3); and IFN-3, plus II:4 (lane 
4). Expression  of G3PDH (C) demonstrated  that equal amounts  of RNA 
were loaded in each lane. 
n =  5) (Fig. 1 A, lane 2). Time course experiments indicated 
that Lsk mRNA expression was observed as early as 6 h after 
IL-4 stimulation, was maximal at 18 h, and remained elevated 
for up to 48 h (data not shown). Coculture with IFN-3, (500 
U/ml) completely inhibited the induction of Lsk by IL-4 
(1.31  _+  0.23 times the level of the medium control, n  =  5) 
(Fig. 1 A, lane 4). As shown in Fig. 2, A and B, IL-4 induc- 
tion of Lsk mRNA and its inhibition by IFN-3' were dose 
dependent. Since IL-2, like IFN-% stimulates several mono- 
cytic functions (19, 21) we investigated the effect of IL-2 on 
Lsk mRNA expression.  Interestingly, IL-2 did not induce 
Lsk mRNA and, in contrast to IFN-3', did not affect IL-4 
induction of Lsk. These data suggest that Lsk expression  in 
human monocytes is tightly regulated by IL-4 and IFN-y. 
Because together Lsk and Csk comprise a unique family 
of kinases, we next analyzed the expression of Csk in IFN-y- 
and IL-4-stimulated monocytes. We found that Csk mtLNA 
was constitutively expressed in human monocytes (Fig. 1 B) 
and unaffected by IL-4 treatment (1.18 _+ 0.07 times the levels 
of control, n  =  3). While IFN-3, did not induce Lsk expres- 
sion in monocytes, Csk mtLNA was slightly increased after 
IFN-3  ~ treatment (1.54  _+  0.24 times the level of control, 
2384  II:4/IL-13  Induction of Lsk in Monocytes Figure 2.  Dose-dependent in- 
duction of Lsk mRNA by IL-4. 
Monocytes  were cultured for 18 h 
in the presence of medium alone 
(lane I) or decreasing  concentrations 
of  IL-4, 100 to 0.1 U/ml (lanes  2-5). 
The same  filter  was subsequently  re- 
hybridized  with a probe  specific  for 
G3PDH to demonstrate  that equal 
amounts of RNA were  loaded. (B) 
IL-4-induced expression  of Lsk in 
monocytes  is antagonized  by IFN-3' 
but not by IL-2. Monocytes  were 
cultured for 18 h in the presence  of 
medium alone (lane I); IL-4, 100 
U/ml  (lane 2),  or  Ib4  plus 
decreasing  concentration  of  IFN-% 
500 to 4 U/ml (lanes 3-6); Ib2, 
1,000 U/ml (lane  7) or IL-2  plus 100 
U/ml IL-4  (lane  8). The same filter 
was subsequently  rebybridized  with 
a probe  specific  for G3PDH  to dem- 
onstrate equal RNA loading. 
Figure 3.  Effect  of  Ib13 and IFN-"/on  Lsk mRNA expression.  Mono- 
cytes were cultured for 18 h in the presence of medium alone (lane 1); 
decreasing concentrations  of IL-13, 50 to 0.1 ng/ml (lanes 2-5); IFN-% 
500 U/ml (lane 6); or II:13, 50 ng/ml plus IFN-% 500 U/ml (lane 7). 
Expression of G3PDH demonstrated equal KNA loading. 
n  --  3). Therefore, the cytokine regulation of Lsk and Csk 
differs  substantially in monocytes. 
Effect of IL-13  on  Lsk  mRNA.  A  recently  identified 
cytokine, IL-13, has been shown to share some of the activi- 
ties of IL-4 (22, 23). Therefore, we examined whether IL-13 
might also upregulate Lsk gene expression. Dose response 
experiments were performed in monocytes stimulated for 18 h 
by IL-13.  Fig.  3  shows that IL-13 induced Lsk mRNA in 
a dose-dependent fashion (IL-13 at 50 ng/ml increased Lsk 
mKNA  to  3.7  +  0.28  times  the level of medium  alone, 
n  --  2). Since Lsk induction by IL-4 was inhibited by IFN-% 
we examined its effect on IL-13-induction of Lsk. As shown 
in Fig.  3,  IFN-3, completely blocked the induction of Lsk 
by IL-13. These results demonstrated that IL-13 induces Lsk 
mRNA in human monocytes and, like IL-4,  IL-13 effects 
are  inhibited by IFN-% 
Induction of p57  Lsk in  IL-4- and IL-13-treated Monocytes. 
We next sought to verify whether Lsk mRNA upregulation 
also results in an induction of p57  Lsk, the protein encoded 
by the Lsk gene. To this end, Western blot analysis was per- 
formed using an anti-Lsk polyclonal rabbit antiserum. Fig. 
4  shows  that  a polypeptide of "~57  kD  corresponding to 
p57  Lsk was detected in total cell lysates of monocytes treated 
with IL-4 (A) or IL-13 (/3) for 48 h, but not in the untreated 
cells. Monocytes treated for 48 h with IFN-%  IFN-3~ plus 
IL-4, or IFN-3~ plus IL-13 did not possess  detectable levels 
of p57  Ls~. The specificity of the Lsk antiserum was demon- 
strated by the ability of the Lsk peptide to compete the binding 
of antiserum to the 57-kD polypeptide but not the 69- or 
52-kD nonspecific bands (data not shown) (14).  Using the 
anti-Csk  antiserum we analyzed the effect of IL-4,  IL-13, 
IFN-3~ treatments on levels of p50  csk. Fig.  5 shows that con- 
sistent with the results of the Northern analysis, p50  cs~ was 
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slightly increased by IFN-'y treatment. 
Discussion 
The Lsk and Csk genes encode structurally related PTKs 
(11, 13,  14). The established role of Csk suggests that both 
kinases may negatively regulate the enzymatic activity of Src 
family members involved in leukocyte activation (9,  11, 17, 
18). However, the fact that  Csk is ubiquitously expressed 
whereas Lsk expression is more limited, indicates differential 
regulation of Csk family members and implies diverse func- 
tions for the different family members. Here we report that 
Lsk is not constitutively expressed in human monocytes, but 
is induced by IL-4 or IL-13 treatment. IFN-y, a potent mono- 
cyte activator, did not induce Lsk; rather, it inhibited IL-4 
or IL-D induction. In contrast, Csk is constitutively expressed 
in human monocytes, not affected by IL-4 or IL-13  treat- 
ment, and upregulated slightly by IFN-% 
Figure 5.  pS0  'S~ expression in human monocytes. Monocytes  were 
treated  for 48 h with medium  (C); I1,4, 100 U/ml; I1,D, 50 ng/ml; IFN-% 
500 U/ml; Ib4 plus IFN-% or IL-D plus IFN-% lysed,  and postnuclear 
supernatants were  electrophoresed  and immunoblotted  using  an anti-Csk 
antiserum. 
Figure 4.  p57  ~'t  expression in 
human  monocytes.  Monocytes  were 
treated  for 48 h with medium  alone 
(C); IL-4, 100 U/ml; IFN-'y, 500 
U/ml; II,4 plus IFN-'y  (A) or 11,13, 
50 ng/ml, or IL-13 plus IFN-',/(B) 
were lysed  and postnuclear super- 
natants were electrophoresed  and 
immunoblotted  using a polyclonal 
rabbit antiserum  generated  against 
the COOH terminus of Lsk. 
IFN-3/  and  IL-4  are produced by functionally different 
subsets  of T  helper cells, Thl  and Th2,  respectively.  IFN- 
"y-producing T clones have been shown to direct the immune 
response towards cytotoxicity by activating monocytes and 
promoting cytotoxic T cell activity. In contrast,  IL-4-secreting 
T  cells preferentially augment a humoral immune response 
by inducing B cell activation and inhibiting monocytic ac- 
tivities (24).  Therefore, IL-4 and IFN-'y, as products of two 
distinct subsets  of T  helper lymphocytes, control the state 
of activation of monocytes. Our data suggest that Lsk regu- 
lation by IL-4 and IFN-'y may play a role in the modulation 
of monocyte functions by T  helper subsets. 
In addition to IFN-% the Thl phenotype is characterized 
by IL-2  production.  We  have  previously shown  that  like 
IFN-'y, IL-2 can activate human monocyte cytotoxicity (25, 
26) and increase the expression of several monocyte genes (19, 
21,  25,  27).  However,  IL-4 blocks  IL-2-induced but  not 
IFN-'y-induced monocyte cytotoxicity (Bosco, M., K. Pulkki, 
A. Zea, T. Musso, D. L. Longo, L. Varesio, and I. Espinoza- 
Delgado, manuscript in preparation).  Since our data show 
that IL-4 is unable to induce Lsk in the presence of IFN-'y, 
but does in the presence of IL-2, IL-4 might inhibit certain 
monocyte activities,  such as cytotoxicity, in part through the 
induction of Lsk. 
Unlike the Src family PTK,  to date there is only one re- 
port of modulation of Lsk or Csk enzymatic activity (28). 
Therefore, the cytokine-mediated transcriptional/translational 
control we have demonstrated here may represent a principle 
mechanism by which the Csk family is regulated. However, 
the differential regulation in human monocytes of these two 
Csk-family genes is intriguing. The fact that Csk is consti- 
tutively present in monocytes is not surprising since Csk has 
been shown to be expressed in all human tissues and cell lines 
tested to date (11-13).  However, the observation that  Csk 
expression can be regulated in human monocytes by cytokines 
has not been previously reported. The constitutive expres- 
sion of Csk and its mild upregulation by IFN-'y, in conjunc- 
tion with the reported upregulation of Fgr, Hck, and Lyn 
2386  Ib4/IL-13  Induction  of Lsk in Monocytes by IFN-',/and/or LPS (6, 7) in monocytes, suggest that Csk 
may function as a general regulator of several Src-family kinase 
activities. Lsk, on the contrary, could preferentially phosphory- 
late certain Src family members or other substrates involved 
in the differential effects of IL-4 and IFN-3, in monocytes. 
This hypothesis is in part supported by structural differences 
in the SH3 domains of Lsk and Csk indicating different in- 
tracellular localizations and/or substrates for these kinases (29). 
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